Microcap Ledger Tenon Medical, Inc. $TNON
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Surgical & Medical Instruments & Apparatus
- Headquarters
- Los Gatos, CA
- Fiscal year end
- December 31
- Shares outstanding
- 667,047 [10-Q 2026-08-13]
What the company doesAI summary of filing
Tenon Medical is a medical device company that develops and sells minimally invasive surgical systems for treating sacroiliac joint disorders. The company offers two product lines: the Catamaran SI Joint Fusion System, which received FDA clearance in 2018 and launched nationally in October 2022, and the SImmetry+ SI Joint Fusion System, acquired in August 2025. Tenon generates revenue by selling these systems to hospitals and surgical facilities through independent distributors and sales representatives; healthcare providers are reimbursed separately by insurers for performing the procedures. The company is revenue-generating, having launched commercial sales of the Catamaran System in 2022, though it has incurred losses and operates on a going concern basis. [10-K 2026-03-27]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $2.66M | −$7.53M | −$5.72M | $1.68M | [10-Q 2026-08-13] |
| FY ended Dec 2025 | $3.94M | −$12.56M | −$10.74M | $3.76M | [10-K 2026-03-27] |
| FY ended Dec 2024 | $3.28M | −$13.67M | −$9.88M | $6.54M | [10-K 2026-03-27] |
- Quarterly cash burn
- −$2.86M
- Cash runway Estimate
- ~1.8 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-11-14 | 3,136,589 | [10-Q 2024-11-14] |
| 2025-03-26 | 5,584,965 | [10-K 2025-03-26] |
| 2025-05-13 | 7,589,970 | [10-Q 2025-05-13] |
| 2025-08-13 | 8,879,220 | [10-Q 2025-08-13] |
| 2025-11-13 | 8,605,740 | [10-Q 2025-11-13] |
| 2026-03-27 | 11,296,378 | [10-K 2026-03-27] |
| 2026-05-15 | 11,573,428 | [10-Q 2026-05-15] |
| 2026-08-13 | 667,047 | [10-Q 2026-08-13] |
- Shelf registration
- S-3 filed 2026-10-05; no effectiveness notice found in EDGAR [S-3 2026-10-05]
Listing status
Current status: 2 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-05-22. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2026-05-22 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-05-22] |
| 2026-02-27 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-02-27] |
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-09-10 | Hrt Financial Lp | buy | 31,227 | $2.92 | [4 2026-09-11] |
| 2026-09-10 | Hrt Financial Lp | buy | 28,267 | $4.02 | [4 2026-09-11] |
| 2026-09-10 | Hrt Financial Lp | buy | 8,431 | $4.92 | [4 2026-09-11] |
| 2026-09-10 | Hrt Financial Lp | sell | 65,582 | $5.56 | [4 2026-09-11] |
| 2026-09-09 | Hrt Financial Lp | sell | 50,395 | $2.61 | [4 2026-09-11] |
| 2026-09-09 | Hrt Financial Lp | buy | 39,508 | $3.40 | [4 2026-09-11] |
| 2026-09-09 | Hrt Financial Lp | sell | 9,948 | $4.27 | [4 2026-09-11] |
| 2026-09-09 | Williamson Kevin | other | 11 | $3.45 | [4 2026-09-10] |
| 2026-09-08 | Hrt Financial Lp | buy | 707 | $3.34 | [4 2026-09-11] |
| 2026-09-08 | Williamson Kevin | exercise | 30 | — | [4 2026-09-10] |
| 2026-09-04 | Hrt Financial Lp | sell | 1,506 | $3.70 | [4 2026-09-08] |
| 2026-09-03 | Hrt Financial Lp | buy | 1,658 | $3.98 | [4 2026-09-08] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-10-09 | 424B3 | Prospectus or prospectus supplement |
| 2026-10-05 | S-3 | Registration statement |
| 2026-09-16 | 8-K | Material agreement entered; Unregistered sale of equity; Other events |
| 2026-09-09 | 8-K | Other events |
| 2026-09-08 | 424B3 | Prospectus or prospectus supplement |
| 2026-09-02 | S-3/A | Registration statement |
| 2026-08-31 | 8-K | Material agreement entered; Unregistered sale of equity; Other events |
| 2026-08-26 | 8-K | Material agreement entered; Unregistered sale of equity; Other events |
| 2026-08-24 | 8-K | Other events |
| 2026-08-17 | S-3/A | Registration statement |
| 2026-08-14 | 13G | Beneficial ownership report (5%+ holder) |
| 2026-08-13 | 10-Q | Quarterly report |
Alerts for $TNON
Email me when Tenon Medical, Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.